 |
 |
 |
 |
 |
 |
 |
 |
-
BROWSE TOPICS IN CLINICAL MANAGEMENT:
Antiretroviral Therapy- Complications of HIV/HAART
- Research & Development
- Clinical Trials
- Quality of Life & Patient Care
Antiretroviral Therapy
Mitochondrial Toxicity
Overview
- Does Mitochondrial Toxicity Drive Lipoatrophy? (July 2003)
Highlights from the IAPAC Sessions 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Mitochondrial Toxicity and Lactic Acidosis Fact Sheet (April 2001)
To read PDF, click here
From Project Inform
Research
- ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes - Ask the Expert: Case Study -- 38-Year-Old Woman With Persistent Flu-Like Symptoms (June 2003)
To read PDF, click here
In HEPP Report, from Brown Medical School - Study Finds Protease Inhibitors May Help Cause Lipodystrophy (October 30, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - The Case Against Zerit (October 2002)
Research increasingly points to NRTIs -- particularly d4T -- as a likely culprit in metabolic disorders.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Mitochondrial Damage (Fall 2002)
To read PDF, click here
In STEP Perspective, from Seattle Treatment Education Project - Mitochondrial Toxicity in HAART (September 2002)
A review of the latest research.
In The PRN Notebook
  |
  |